Reader Offer – Ovusense Pro

What is it?

OvuSense is a fully approved Class II medical device for measuring core body temperature (CBT). This allows patients who are trying to conceive achieve pregnancy by learning their ovulation pattern. With the launch of OvuSense Pro, this data can now be accessed by the patient’s healthcare provider.

How does it work?

Ovusense uses a specially designed sensor, placed in the vagina overnight, to measure CBT with a resolution of 0.003˚ Celsius. The data from the sensor is downloaded each morning to the dedicated OvuSense App.

Key information

• CBT is a proxy for the level of progesterone. The rise in CBT associated with progesterone release during ovulation is consistent in all women. CBT is more accurate for predicting and confirming the date of ovulation than any other home based method currently available
• Prediction accuracy is clinically proven with Ovusense with a positive predictive value of 96% for informing the user up to 24 hours in advance when they are going to ovulate using current cycle data and a 99% accuracy for confirming the date of ovulation^{1, 2}
• OvuSense Pro shares information between OvuSense users and their health care professionals. This provides you as a fertility specialist with complete details of patient charts and events such as medication dosage and timing. This is all logged in the patient’s OvuSense app, which is shared with you via the OvuSense Pro portal
• Automatic recognition of a range of atypical cycle patterns. The analysis of cycle patterns can aid diagnosis of ovulatory issues, miscarriage risk and potential pregnancy complications.³

Your patients can benefit for a 30% discount when using HUB30 at checkout. Please click here for detailed healthcare provider information.

References

1. Papaioannou S, et al. 2014. Vaginal core body temperature assessment identifies pre-ovulatory body temperature rise and detects ovulation in advance of ultrasound folliculometry. Poster presented at ESHRE Congress. 29 June – 2 July 2014. Munich, Germany.
2. Papaioannou S, et al. 2013. Quality index assessment of vaginal temperature-based fertility prediction and comparison with luteinising hormone testing, ultrasound folliculometry and other home cycle monitors. Fert Steril. Volume 100, Issue 3, Supplement, Pages S326–S327.
3. Hurst B, et al. Atypical vaginal temperature patterns may identify subtle, not yet recognized, causes of infertility. Poster presented at the ASRM Congress. 12-16 October 2019. Philadelphia, USA.